NEWS
Cancer test scores $4m in capital for biotech
SYDNEY: Early-stage biotech BCAL Diagnostics has closed a $4 million pre-IPO capital raise ... read more
IOOF now backs executive in abuse claim
MELBOURNE: IOOF is standing behind its deputy chief investment officer, Stanley Yeo, despite ... read more